Radical Hypofractionated Radiotherapy for Localized Prostate Cancer

This study tests a radiation therapy approach for prostate cancer called hypofractionated radiotherapy — where a higher dose is given over fewer sessions compared to traditional radiation. This can be more convenient for patients and may be equally effective. Researchers are evaluating its safety, effectiveness, and impact on quality of life. **You may be eligible if...** - You are 18 or older - You have been diagnosed with prostate cancer confirmed by biopsy - Your cancer is any stage that hasn't spread to distant organs (cTanyN0M0) - You are expected to live more than 5 years - You are in good general health (ECOG score 2 or less) - You are willing to participate after being informed of other treatment options **You may NOT be eligible if...** - You have already received treatment for prostate cancer (radiation, chemotherapy, hormone therapy, focal therapy) - You have had previous radiation to the pelvis or abdomen - You have another active cancer - You have severe urinary problems after surgery Talk to your doctor to see if this trial is right for you.